Bank of America Securities: Gives China Life Insurance (02628) a "buy" rating with a target price of 33.1 Hong Kong dollars.

16:11 27/03/2026

Market concerns about China Life's performance in the first quarter of this year. Due to the fact that general investors did not seem to anticipate a loss in the last quarter, the market reaction has been negative.

Bank of America Securities released a research report stating that the target price of China Life Insurance (02628) is HK$33.1 and rating it as "buy". Under the influence of macroeconomic uncertainties, the market trend is unclear, and investors are currently reluctant to buy high beta (high volatility) stocks such as China Life Insurance. There are concerns in the market about the performance of China Life Insurance in the first quarter of this year. As general investors did not seem to anticipate a loss in the previous quarter, the market response has been negative. On the other hand, the company's dividend per share growth last year met investor expectations. The bank mentioned that as one of the most aggressive insurers in terms of investment strategy, the stock performance of China Life Insurance and New China Life Insurance (01336) has lagged behind more conservative peers such as Ping An (02318) and Taiping (02601).

CHARMACY PHAR (02289): Wong Wai Ling resigns as Joint Company Secretary.

SWANGCHAICHUAN (02321) announced its annual performance, with a net profit of 33.238 million ringgit, an increase of 18.44% year-on-year.

SUNWAY INT'L (00058) announces annual financial results, with a net loss attributable to shareholders of HK$40.208 million, a decrease of 28.36% year-on-year.

CHARMACY PHAR (02289): Wong Wai Ling resigns as Joint Company Secretary.

SWANGCHAICHUAN (02321) announced its annual performance, with a net profit of 33.238 million ringgit, an increase of 18.44% year-on-year.

SUNWAY INT'L (00058) announces annual financial results, with a net loss attributable to shareholders of HK$40.208 million, a decrease of 28.36% year-on-year.